Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q4 2020 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2021-02-12

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value: $131M (100.0% shares, 0.0% debt)

Holdings (21)

LGND LIGAND PHARMACEUTICALS 24.8%

Value $32.43M Shares 326,100 Share Price $99.45 * Est. Cost/Share $64.80 Unrealized @ Report Date -12.0%

— AMRYT PHARMA LTD - SPNR ADR 15.4%

Value $20.06M Shares 1,416,483 Share Price $14.16 Est. Cost/Share $13.19 Unrealized @ Report Date —

DMAC DIAMEDICA THERAPEUTICS INC 7.4%

Value $9.633M Shares 950,000 Share Price $10.14 * Est. Cost/Share $4.62 Unrealized @ Report Date +18.5%

— AYTU BIOSCIENCE INC 6.4%

Value $8.365M Shares 1,398,776 Share Price $5.98 Est. Cost/Share $5.98 Unrealized @ Report Date —

— APOLLO ENDOSURGERY INC 6.1%

Value $7.909M Shares 2,326,165 Share Price $3.40 Est. Cost/Share $3.98 Unrealized @ Report Date —

— CTI BIOPHARMA CORP 5.1%

Value $6.614M Shares 2,054,000 Share Price $3.22 Est. Cost/Share $2.16 Unrealized @ Report Date —

— IVERIC BIO INC 4.2%

Value $5.528M Shares 800,000 Share Price $6.91 Est. Cost/Share $1.52 Unrealized @ Report Date —

XOMA XOMA CORP 4.2%

Value $5.478M Shares 124,130 Share Price $44.13 * Est. Cost/Share $14.24 Unrealized @ Report Date +111.7%

— CATALYST BIOSCIENCES INC 4.0%

Value $5.265M Shares 834,449 Share Price $6.31 Est. Cost/Share $4.61 Unrealized @ Report Date —

SCYX SCYNEXIS INC 4.0%

Value $5.24M Shares 685,000 Share Price $7.65 * Est. Cost/Share $5.86 Unrealized @ Report Date 0.0%

— ADAMAS PHARMACEUTICALS INC 2.7%

Value $3.501M Shares 808,431 Share Price $4.33 Est. Cost/Share $4.72 Unrealized @ Report Date —

— STRONGBRIDGE BIOPHARMA PLC 2.5%

Value $3.281M Shares 1,350,000 Share Price $2.43 Est. Cost/Share $2.10 Unrealized @ Report Date —

— GAMIDA CELL LTD 2.4%

Value $3.184M Shares 379,470 Share Price $8.39 Est. Cost/Share $8.39 Unrealized @ Report Date —

— CHIASMA INC 2.4%

Value $3.138M Shares 721,307 Share Price $4.35 Est. Cost/Share $4.33 Unrealized @ Report Date —

— NEOS THERAPEUTICS INC 2.4%

Value $3.1M Shares 4,962,657 Share Price $0.62 Est. Cost/Share $1.66 Unrealized @ Report Date —

— NOVUS THERAPEUTICS INC 2.0%

Value $2.577M Shares 167,333 Share Price $15.40 Est. Cost/Share $15.40 Unrealized @ Report Date —

— YUMANITY THERAPEUTICS INC 1.4%

Value $1.85M Shares 108,847 Share Price $17.00 Est. Cost/Share $17.00 Unrealized @ Report Date —

— AFFIMED NV 1.0%

Value $1.277M Shares 219,340 Share Price $5.82 Est. Cost/Share $3.39 Unrealized @ Report Date —

— VISTAGEN THERAPEUTICS INC 0.7%

Value $970K Shares 500,000 Share Price $1.94 Est. Cost/Share $1.94 Unrealized @ Report Date —

— APTEVO THERAPEUTICS INC 0.5%

Value $670K Shares 18,280 Share Price $36.65 Est. Cost/Share $36.65 Unrealized @ Report Date —

CPIX CUMBERLAND PHARMACEUTICALS 0.4%

Value $557K Shares 188,703 Share Price $2.95 * Est. Cost/Share $5.80 Unrealized @ Report Date -47.8%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
LGND	LIGAND PHARMACEUTICALS	326,100	$32.43M	24.8%	$99.45 *	$64.80	-12.0%	COM NEW	53220K504
—	AMRYT PHARMA LTD - SPNR ADR	1,416,483	$20.06M	15.4%	$14.16	$13.19	—	SPONSORED ADS	03217L106
DMAC	DIAMEDICA THERAPEUTICS INC	950,000	$9.633M	7.4%	$10.14 *	$4.62	+18.5%	COM NEW	25253X207
—	AYTU BIOSCIENCE INC	1,398,776	$8.365M	6.4%	$5.98	$5.98	—	COM	054754874
—	APOLLO ENDOSURGERY INC	2,326,165	$7.909M	6.1%	$3.40	$3.98	—	COM	03767D108
—	CTI BIOPHARMA CORP	2,054,000	$6.614M	5.1%	$3.22	$2.16	—	COM	12648L601
—	IVERIC BIO INC	800,000	$5.528M	4.2%	$6.91	$1.52	—	COM	46583P102
XOMA	XOMA CORP	124,130	$5.478M	4.2%	$44.13 *	$14.24	+111.7%	COM NEW	98419J206
—	CATALYST BIOSCIENCES INC	834,449	$5.265M	4.0%	$6.31	$4.61	—	COM NEW	14888D208
SCYX	SCYNEXIS INC	685,000	$5.24M	4.0%	$7.65 *	$5.86	0.0%	COM NEW	811292200
—	ADAMAS PHARMACEUTICALS INC	808,431	$3.501M	2.7%	$4.33	$4.72	—	COM	00548A106
—	STRONGBRIDGE BIOPHARMA PLC	1,350,000	$3.281M	2.5%	$2.43	$2.10	—	SHS USD	G85347105
—	GAMIDA CELL LTD	379,470	$3.184M	2.4%	$8.39	$8.39	—	SHS	M47364100
—	CHIASMA INC	721,307	$3.138M	2.4%	$4.35	$4.33	—	COM	16706W102
—	NEOS THERAPEUTICS INC	4,962,657	$3.1M	2.4%	$0.62	$1.66	—	COM	64052L106
—	NOVUS THERAPEUTICS INC	167,333	$2.577M	2.0%	$15.40	$15.40	—	COM	67011N204
—	YUMANITY THERAPEUTICS INC	108,847	$1.85M	1.4%	$17.00	$17.00	—	COM	98872L102
—	AFFIMED NV	219,340	$1.277M	1.0%	$5.82	$3.39	—	COM	N01045108
—	VISTAGEN THERAPEUTICS INC	500,000	$970K	0.7%	$1.94	$1.94	—	COM NEW	92840H202
—	APTEVO THERAPEUTICS INC	18,280	$670K	0.5%	$36.65	$36.65	—	COM NEW	03835L207
CPIX	CUMBERLAND PHARMACEUTICALS	188,703	$557K	0.4%	$2.95 *	$5.80	-47.8%	COM	230770109